Exane Derivatives Price T Rowe Group Inc Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Price T Rowe Group Inc stock. As of the latest transaction made, Exane Derivatives holds 2 shares of TROW stock, worth $239. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2
Previous 2
-0.0%
Holding current value
$239
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TROW
# of Institutions
1,179Shares Held
166MCall Options Held
2.2MPut Options Held
2.17M-
Vanguard Group Inc Valley Forge, PA25.9MShares$3.11 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY19.7MShares$2.36 Billion0.05% of portfolio
-
State Street Corp Boston, MA14.3MShares$1.72 Billion0.06% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA6.84MShares$820 Million0.14% of portfolio
-
Fayez Sarofim & CO Houston, TX5.63MShares$674 Million1.58% of portfolio
About PRICE T ROWE GROUP INC
- Ticker TROW
- Exchange NASDAQ
- Sector Financial Services
- Industry Asset Management
- Shares Outstandng 225,692,000
- Market Cap $27B
- Description
- T. Rowe Price Group, Inc. is a publicly owned investment manager. The firm provides its services to individuals, institutional investors, retirement plans, financial intermediaries, and institutions. It launches and manages equity and fixed income mutual funds. The firm invests in the public equity and fixed income markets across the globe. It e...